학술논문
Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancreatic adenocarcinoma
Document Type
Source
In Cancer Treatment and Research Communications 2021 27
Subject
Language
ISSN
2468-2942